These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 33435904

  • 1. A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial.
    Hague WM, Callaway L, Chambers J, Chappell L, Coat S, de Haan-Jebbink J, Dekker M, Dixon P, Dodd J, Fuller M, Gordijn S, Graham D, Heikinheimo O, Hennessy A, Kaaja R, Khong TY, Lampio L, Louise J, Makris A, Markus C, Marschall HU, Middleton P, Mol BW, Morris J, Newnham JP, Ovadia C, Peek M, Shand A, Stark M, Thornton J, Timonen S, Walker S, Warrilow D, Williamson C.
    BMC Pregnancy Childbirth; 2021 Jan 12; 21(1):51. PubMed ID: 33435904
    [Abstract] [Full Text] [Related]

  • 2. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC, Chambers J, Dixon PH, Dorling J, Hunter R, Bell JL, Bowler U, Hardy P, Juszczak E, Linsell L, Rounding C, Smith A, Williamson C, Thornton JG.
    Trials; 2018 Nov 27; 19(1):657. PubMed ID: 30482254
    [Abstract] [Full Text] [Related]

  • 3. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy.
    Geenes V, Chambers J, Khurana R, Shemer EW, Sia W, Mandair D, Elias E, Marschall HU, Hague W, Williamson C.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun 27; 189():59-63. PubMed ID: 25864112
    [Abstract] [Full Text] [Related]

  • 4. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial.
    Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG, PITCH Study Consortium.
    BMJ; 2012 Jun 13; 344():e3799. PubMed ID: 22695903
    [Abstract] [Full Text] [Related]

  • 5. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X, Kong Y, Zhang F, Wang T, Yan J.
    Medicine (Baltimore); 2016 Oct 13; 95(40):e4949. PubMed ID: 27749550
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy.
    Walker KF, Chappell LC, Hague WM, Middleton P, Thornton JG.
    Cochrane Database Syst Rev; 2020 Jul 27; 7(7):CD000493. PubMed ID: 32716060
    [Abstract] [Full Text] [Related]

  • 7. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG, PITCHES study group.
    Lancet; 2019 Sep 07; 394(10201):849-860. PubMed ID: 31378395
    [Abstract] [Full Text] [Related]

  • 8. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A, Marschall HU, Lammert F, Mattsson LA.
    Hepatology; 2005 Dec 07; 42(6):1399-405. PubMed ID: 16317669
    [Abstract] [Full Text] [Related]

  • 9. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U.
    BMC Gastroenterol; 2015 Jul 29; 15():92. PubMed ID: 26215400
    [Abstract] [Full Text] [Related]

  • 10. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M, Czajkowski K, Smolarczyk R.
    Scand J Gastroenterol; 2016 Jan 29; 51(1):78-85. PubMed ID: 26152830
    [Abstract] [Full Text] [Related]

  • 11. Feto-Maternal Effects of Adding Rifampicin to Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy.
    Kumari A, Kumar A, Kumar M, Swati S.
    Cureus; 2022 Dec 29; 14(12):e32509. PubMed ID: 36654556
    [Abstract] [Full Text] [Related]

  • 12. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis.
    Ovadia C, Sajous J, Seed PT, Patel K, Williamson NJ, Attilakos G, Azzaroli F, Bacq Y, Batsry L, Broom K, Brun-Furrer R, Bull L, Chambers J, Cui Y, Ding M, Dixon PH, Estiú MC, Gardiner FW, Geenes V, Grymowicz M, Günaydin B, Hague WM, Haslinger C, Hu Y, Indraccolo U, Juusela A, Kane SC, Kebapcilar A, Kebapcilar L, Kohari K, Kondrackienė J, Koster MPH, Lee RH, Liu X, Locatelli A, Macias RIR, Madazli R, Majewska A, Maksym K, Marathe JA, Morton A, Oudijk MA, Öztekin D, Peek MJ, Shennan AH, Tribe RM, Tripodi V, Türk Özterlemez N, Vasavan T, Wong LFA, Yinon Y, Zhang Q, Zloto K, Marschall HU, Thornton J, Chappell LC, Williamson C.
    Lancet Gastroenterol Hepatol; 2021 Jul 29; 6(7):547-558. PubMed ID: 33915090
    [Abstract] [Full Text] [Related]

  • 13. The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies.
    Grand'Maison S, Durand M, Mahone M.
    J Obstet Gynaecol Can; 2014 Jul 29; 36(7):632-641. PubMed ID: 25184983
    [Abstract] [Full Text] [Related]

  • 14. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C.
    J Hepatol; 2021 May 29; 74(5):1087-1096. PubMed ID: 33276032
    [Abstract] [Full Text] [Related]

  • 15. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F, Zhang L, He MM, Liu ZF, Gao BX, Wang XD.
    Curr Med Res Opin; 2014 Aug 29; 30(8):1529-35. PubMed ID: 24665980
    [Abstract] [Full Text] [Related]

  • 16. Ursodeoxycholic acid improves pregnancy outcome in patients with intrahepatic cholestasis during pregnancy: A protocol for systematic review and meta-analysis.
    Wang Y, Peng X, Zhang Y, Yang Q, Xiao Y, Chen Y.
    Medicine (Baltimore); 2021 Jan 29; 100(4):e23627. PubMed ID: 33530164
    [Abstract] [Full Text] [Related]

  • 17. [Intrahepatic cholestasis of pregnancy: French College of Obstetricians and Gynecologists guidelines for clinical practice].
    Sentilhes L, Sénat MV, Bouchghoul H, Delorme P, Gallot D, Garabedian C, Madar H, Sananès N, Perrotin F, Schmitz T.
    Gynecol Obstet Fertil Senol; 2023 Jan 29; 51(11-12):493-510. PubMed ID: 37806861
    [Abstract] [Full Text] [Related]

  • 18. Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy.
    Roy A, Premkumar M, Mishra S, Mehtani R, Suri V, Aggarwal N, Singh S, Dhiman RK.
    Eur J Gastroenterol Hepatol; 2021 Apr 01; 33(4):571-576. PubMed ID: 33136720
    [Abstract] [Full Text] [Related]

  • 19. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial.
    Joutsiniemi T, Timonen S, Leino R, Palo P, Ekblad U.
    Arch Gynecol Obstet; 2014 Mar 01; 289(3):541-7. PubMed ID: 23978872
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.
    Bacq Y, Sentilhes L, Reyes HB, Glantz A, Kondrackiene J, Binder T, Nicastri PL, Locatelli A, Floreani A, Hernandez I, Di Martino V.
    Gastroenterology; 2012 Dec 01; 143(6):1492-501. PubMed ID: 22892336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.